To confirm that the lack of expression of PAX6 mRNA in the HCC lines was due to promoter hypermethylation, we treated cells with 5-aza-2′-deoxycytidine (5DAC), an inhibitor of DNA methylation. Here, PAX6 is linked to hepatocellular carcinoma.